172 related articles for article (PubMed ID: 7915481)
1. Topical calcipotriol for psoriasis--an immunohistologic study.
Mozzanica N; Cattaneo A; Schmitt E; Diotti R; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():171-2. PubMed ID: 7915481
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis vulgaris with topical calcipotriol: is the clinical improvement of lesional skin related to a down-regulation of some cell adhesion molecules?
Cagnoni ML; Ghersetich I; Lotti T; Pierleoni M; Landi G
Acta Derm Venereol Suppl (Stockh); 1994; 186():55-7. PubMed ID: 8073838
[TBL] [Abstract][Full Text] [Related]
4. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy.
Thomson AW; Nalesnik MA; Rilo HR; Woo J; Carroll PB; Van Thiel DH
Autoimmunity; 1993; 15(3):215-23. PubMed ID: 7505632
[TBL] [Abstract][Full Text] [Related]
7. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
[TBL] [Abstract][Full Text] [Related]
8. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis.
El-Domyati M; Barakat M; Abdel-Razek R; El-Din Anbar T
Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis.
Savoia P; Novelli M; De Matteis A; Verrone A; Bernengo MG
J Cutan Pathol; 1998 Feb; 25(2):89-94. PubMed ID: 9521497
[TBL] [Abstract][Full Text] [Related]
11. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions and adhesion molecules in psoriatic skin.
de Boer OJ; Verhagen CE; Visser A; Bos JD; Das PK
Acta Derm Venereol Suppl (Stockh); 1994; 186():15-8. PubMed ID: 7915480
[TBL] [Abstract][Full Text] [Related]
13. The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis.
Torres-Alvarez B; Castanedo-Cazares JP; Fuentes-Ahumada C; Moncada B
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):334-9. PubMed ID: 17309454
[TBL] [Abstract][Full Text] [Related]
14. Calcipotriol induces apoptosis in psoriatic keratinocytes.
Tiberio R; Bozzo C; Pertusi G; Graziola F; Gattoni M; Griffanti P; Boggio P; Colombo E; Leigheb G
Clin Exp Dermatol; 2009 Dec; 34(8):e972-4. PubMed ID: 19758385
[TBL] [Abstract][Full Text] [Related]
15. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
16. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
17. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
18. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
[TBL] [Abstract][Full Text] [Related]
20. Structural alterations of basal keratinocytes and capillary loop in psoriasis during treatment with topical calcipotriol.
Palleschi GM; Gentili A; Caproni M; Giacomelli A; Falcos D; Fabbri P
Acta Derm Venereol Suppl (Stockh); 1994; 186():49-51. PubMed ID: 8073836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
